Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
GPN Vaccines Reports Positive Safety and Immunogenicity Data from its Phase 1 Trial of Gamma-PN 2024-01-04 04:30
Mr. Chong-Yoon Lim, Chairman of COREE Group emphasizes "Creative destruction and Healthcare 4.0" [New Year Message at X-Twitter SNS] 2024-01-03 22:00
Turn Biotechnologies' Expanded eTurna™ Delivery Platform Designed to Solve Delivery and Targeting Issues that Challenge Industry 2024-01-03 22:00
Brii Biosciences Appoints Dr. Brian Alvin Johns as Chief Scientific Officer 2024-01-03 20:00
Ribo partners with Boehringer Ingelheim to develop new treatments for people with liver diseases 2024-01-03 19:37
Belief BioMed Successfully Completed Dosing of First Subject in the Registrational Clinical Trial for Hemophilia A 2024-01-03 18:10
Bangkok Dusit Medical Services strengthens partnership with CNN focusing on global health issues and solutions 2024-01-03 11:30
Sciwind Biosciences Announces Positive Topline Results from Phase 3 Clinical Trial of Ecnoglutide (XW003), a Long-acting cAMP Signaling Biased GLP-1 Analog, in Adult Patients with Type 2 Diabetes in China 2024-01-03 10:00
WuXi XDC Enters into Partnership Agreement with IntoCell, Enabling Clients to Accelerate ADC Discovery and Development 2024-01-03 09:28
Meihua International Medical Technologies Co., Ltd. Announces Closing of Initial $6 Million Tranche of Potential $50.5 Million Maximum Offering 2024-01-03 06:19
Allorion Therapeutics Announces Exclusive Option and Global License Agreement for Novel Preclinical-Stage EGFR L858R Allosteric Inhibitor Program with AstraZeneca 2024-01-02 22:00
MediLink Therapeutics Announces Worldwide Collaboration and License Agreement with Roche to develop next-generation antibody drug conjugate in Oncology 2024-01-02 22:00
Novel Device Facilitates Successful No-Shave FUE Transplants for Long Hair with Ease 2024-01-02 21:00
YolTech Therapeutics to Present and Unveil Major Progress at Biotech Showcase 2024 2024-01-02 20:30
Pulnovo Medical Announces PADN Receives FDA HUD Designation and US CMS Medicare Coverage Code and NMPA Approval 2024-01-02 20:30
Gannex Announces Positive Interim Results from 52-Week Phase II Clinical Trial of Once-Daily ASC41 Tablet in Patients with Biopsy-Confirmed Non-alcoholic Steatohepatitis 2024-01-02 20:06
Mabwell to attend 42nd JP Morgan Healthcare Conference and present at Biotech Showcase 2024-01-02 17:15
Ascentage Pharma to Present at 42nd J.P. Morgan Healthcare Conference 2024-01-02 11:58
Xinhua Silk Road: Xinhua-Yushu Wild Cordyceps Sinensis Price Index unveiled in Beijing 2024-01-02 10:06
Demron by RST - Advanced Protection Against Today's Nuclear Threats 2024-01-02 08:00
1 127 128 129 130 131 982